Correlation between high density lipoprotein and monocyte subpopulations among stable coronary atherosclerotic heart

Rong-Hai Yang1, Ying-Feng Liu2, Xue-Jun Wang3

  • 1Department of Cardiology, Zhujiang Hospital of Southern Medical University Guangzhou 510280, China ; Department of Emergency, Sanshui Hosipital Foshan 528100, China.

Insights

Small high-density lipoprotein (HDL) levels correlate with increased proinflammatory non-classical monocytes and decreased classical monocytes in coronary artery disease (CAD) patients, suggesting a link to atherosclerosis development.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Lipid Metabolism

Background:

  • High-density lipoprotein (HDL) is heterogeneous, and its role in atherosclerosis is not fully understood.
  • Small HDL particles may be imbalanced in patients with Coronary Atherosclerotic Heart Disease (CAD).
  • Monocytes, crucial in atherosclerosis, are classified into three subpopulations based on CD14 and CD16 expression.

Purpose of the Study:

  • To investigate the relationship between HDL levels and monocyte subpopulations in CAD patients.
  • To determine if HDL particle size correlates with specific monocyte subsets in stable CAD.

Main Methods:

  • Studied 90 stable CAD patients.
  • Defined monocyte subpopulations: classical (CM), intermediate (IM), and non-classical (NCM) based on CD14/CD16.
  • Measured HDL levels using polyacrylamide gel electrophoresis.

Main Results:

  • Small HDL in serum correlated with proinflammatory NCM.
  • Small HDL showed a negative correlation with CM.
  • No relationship was found with diabetes, HbA1c, hypertension, smoking, statin dose, or disease severity.

Conclusions:

  • Micromolecule HDL levels correlate with increased NCM and decreased CM.
  • This suggests a proinflammatory link between small HDL and innate immunity in stable atherosclerosis.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
957
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
812
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Inflammation01:38

Inflammation

Overview
64.3K